Effective Life Cycle Management (LCM) is a critical factor for successful commercialisation of pharmaceutical R&D output. This conference offers a unique opportunity to gain insight in the portfolio planning strategies of pharmaceutical companies. 

Leading European life science experts from pharma/biotech business and research, contract research, IP and regulatory authorities will share their experience at the conference, which was tailored specifically for decision makers.

Moderation: Dr. Claire Skentelbery, Secretary General, European Biotechnology Foundation, Brussels

Image Gallery

Programme

09:00

Welcome Address

Marc Geleyn,
Ambassador of the Kingdom of Belgium

 

Welcome Address

Dr. Hans-Rainer Jaenichen,
Vossius & Partner

 

 

Keynote

Portfolio Management - The Art
of Making the Right Choices

Roger Holdsworth, Director R&D Portfolio Management, UCB Pharma



 

Strategy

New Patents with Old Chemical Entities

Dr. Chris Tanner, Chief Financial Officer, Cosmo Pharmaceuticals S.p.A.

 

 

Strategy

Customer Value Integration:
Maximizing Profit and Leverage Innovation

Brigitte Reutter-Härle, Director Corporate Marketing, Vetter Pharma Intl.

 

10:30

Coffee Break

11:00

Intellectual Property

Patent Term Extension in Europe

Dr. Christian Kilger, Patent Attorney, Vossius & Partner

 

 

Intellectual Property

The Goings in Big Pharma

Dr. Christof Bull, Director,
Senior Patent Counsel, UCB Pharma

 

 

Intellectual Property

Life Cycle Management
in Diagnostics

Dr. Jürgen Schneider, Global Senior Director IP & Letigation, Qiagen

 

12:30

Lunch

13:30

Optimisation

Me-betters – HESylation: Optimisation of Protein Drugs

Dr. Peter Vorstheim, Senior Vice President, Fresenius Kabi

 

 

Pharma

Multiple Sclerosis – The Rebif Life Cycle Story

Dr. Reinoud Driebergen, Global Product Team Leader Rebif, Merck-Serono

 

 

Advanced Therapies

The ChondroCelect Experience

Gil Beyen, CEO, TiGenix N.V.

 

15:00

Coffee Break

15:30

Politics

Reimbursement - The Payors View

PD Dr. med. Matthias Perleth, Gemeinsamer Bundesausschuss



 

Strategy

Market Modelling
and Decision Making

Dr. Michael Motz, Director Global Business Development, Roche Pharma Partnering



 

Discussion/Wrap-up

Avoiding the Patent Cliff – Lessons Learned

Dr. Claire Skentelbery, Secretary General,
European Biotechnology Foundation

 

17:00

Networking Cocktail reception

When & where

CONTACT & INFORMATION

 

 

Uta Holmer

Dipl.-Volkswirtin

Veranstaltungsmanagement

 

 

Telefon: +49-30-264921-53

events[at]biocom.de